TITAN BIOTECH LTD. Share Price

₹ 413.55

+₹5.45 (1.34%)
1D
Last updated 18 Nov, 2026, 15:53 IST
BSE: 524717
|
Pharmaceuticals

TITAN BIOTECH LTD. Share Price Today

As of 19 Nov 2026, TITAN BIOTECH LTD. share price is ₹413.55. The stock opened at ₹417.95, compared to its previous close of ₹408.10. During today's trading session, TITAN BIOTECH LTD. share price moved in the range of ₹404.15 to ₹420.30, with an average price of ₹412.23 for the day. Looking at its last 52-week, the stock has touched a low of ₹137.12 and a high of ₹444.52.

Share price over the last 1 day fell from 417.35 to 412.00, ranging between 405.05 and 419.90.

₹404.15
1.34% up today
₹420.30
1D LOW
1D HIGH

TITAN BIOTECH LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 18.85% QoQ
Latest Earning
Net Profit TrendUp by 19.77% QoQ
Latest Earning
Revenue TrendUp by 28.21% QoQ
Stock Performance
OutperformingBeat Nifty by 13.98 % in last 1 month
TITAN BIOTECH LTD. stock performance
Open₹417.95
High₹420.30
Low₹404.15
Prev. close₹408.10
TITAN BIOTECH LTD. trading activity
Volume64,225
Average traded price₹413.59
Last traded time03:53:42 18 Nov
Last traded quantity6

Circuit
L
H
₹367.30
₹448.90
52-week
L
H
₹137.12
₹444.52
Mkt Cap Cr
1,988.45

P/E
54.49

P/B
10.39

ROA
14.34%
ROE
19.06%

ROCE
23.79%

Quick Ratio
1.14

EV/EBITDA
36.22

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Titan Biotech outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Titan Biotech appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Titan Biotech revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,49,227.4940.845.039.61%13.79%18.65%2.3123.45
Divis Laboratories2,93,873.7287.3916.3315.31%18.69%23.83%3.559.08
Torrent Pharmaceuticals1,78,390.6284.659.674.7%11.42%11.37%0.7534.13
Laurus Labs1,26,433.0694.8920.8611.58%22.11%20.91%0.6850.63
Zydus Lifesciences1,19,969.7927.894.317.63%15.1%14.86%0.9115.93
Dr. Reddy's Laboratories1,15,852.1741.982.994.79%7.21%8.58%1.3519.41
Cipla1,11,730.9239.163.166.6%8.18%10.8%2.521.27
Mankind Pharma1,07,612.7047.546.127.82%12.76%14.68%0.7426.3
Aurobindo Pharma1,03,145.1225.872.626.46%10.13%12.76%1.1512.45
Lupin90,201.0517.113.7213.08%21.65%24.54%1.4210.13

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

TITAN BIOTECH LTD. Company Background

ISIN
INE150C01029
Sector Market Cap
₹ 1,988.45 Cr

Titan Biotech Limited is an India-based manufacturer and exporter of biological products. The Company is a manufacturer of clinically approved collagen (fish, bovine, and chicken), skin care ingredients, bone and joint care ingredients, proteins, animal nutrition ingredients and many more. It can provide any microbiology product that its customers need from powder culture media to prepared media. Its product categories include food ingredients, collagen and proteins, pharmaceuticals and nutraceuticals, animal nutrition, probiotics and fermentation ingredients, agriculture products, and culture media. The Company's food ingredients include flavoring and food preservative and improvers. Its collagen and proteins include wheat protein hydrolysate and collagen peptides. Its nutraceuticals include milk protein and bovine cartilage extract. Its animal nutrition includes binding agent, chelates minerals and yeast. Its agriculture products include bio fungicide, insecticides and acaricides.

TITAN BIOTECH LTD. Financial Highlights

  • Revenue: TITAN BIOTECH LTD. reported revenue of ₹211.60 crore in FY26 vs ₹160.36 crore in FY25. It showed an increase of 31.95% on a yearly basis.
  • Operating Profit: TITAN BIOTECH LTD. reported an operating profit of ₹38.17 crore in FY26 vs ₹24.37 crore in FY25. It showed an increase of 56.63% on a year-on-year basis.
  • Net Profit: TITAN BIOTECH LTD. reported a net profit of ₹27.45 crore in FY26 vs ₹18.27 crore in FY25. It showed an increase of 50.25% on a yearly basis.

TITAN BIOTECH LTD. Quarterly Result Highlights

  • TITAN BIOTECH LTD. reported revenue of ₹78.18 crore in Sep 2026, compared with ₹60.98 crore in Jun 2026, representing an increase of 28.21% on a quarter-on-quarter (QoQ) basis.
  • TITAN BIOTECH LTD. reported an operating profit of ₹15.13 crore in Sep 2026, compared with ₹12.73 crore in Jun 2026, representing an increase of 18.85% on a quarter-on-quarter (QoQ) basis.
  • TITAN BIOTECH LTD. reported a profit of ₹11.33 crore in Sep 2026, compared with ₹9.46 crore in Jun 2026, reflecting an increase of 19.77% on a QoQ basis.
  • The earnings per share (EPS) of TITAN BIOTECH LTD. stood at ₹7.23 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
55.78%
FII
0.00%
Other DII
0.01%
Retail and other
44.21%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

TITAN BIOTECH LTD. Investment Returns

1 day
+1.34%

1 week
+12.16%

1 month
+27.04%

1 year
+160.90%

3 years
+568.42%

5 years
+896.03%

TITAN BIOTECH LTD. Share Price History

TITAN BIOTECH LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
18 Nov 26
₹417.95 / ₹413.55
+1.34%
17 Nov 26
₹385.00 / ₹408.10
+6.00%
16 Nov 26
₹370.00 / ₹385.00
+5.00%
13 Nov 26
₹375.00 / ₹366.65
-1.17%
Show more

TITAN BIOTECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹206.19₹156.45₹164.07₹144.00
Other Income₹5.41₹3.91₹1.75₹1.94
Total Revenue₹211.60₹160.36₹165.82₹145.94
Total Expenses₹173.43₹136.00₹134.29₹117.83
Profit Before Tax₹38.17₹24.37₹31.53₹28.12
Tax₹10.73₹6.10₹7.87₹7.09
Profit After Tax₹27.45₹18.27₹23.66₹21.02
EPS - Basic₹7.23₹26.06₹30.07₹30.06
EPS - Diluted₹7.23₹26.06₹30.07₹30.06

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2023Mar 2024Mar 2025Mar 2026
Operating21.1821.1520.1230.42
Investing-20.73-20.3-9.85-32.55
Financing-2.4-2.87-7.98-1.53

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹128.64₹95.20₹84.41₹66.21
Current Assets₹85.24₹79.51₹72.62₹68.31
Total Assets₹213.88₹174.71₹157.03₹134.52
Current Liabilities₹25.96₹17.74₹19.57₹20.35
Net Current Asset₹59.28₹61.77₹53.05₹47.96
Non-Current Liabilities₹6.37₹3.57₹4.00₹4.25
Equity Capital₹181.55₹153.40₹133.45₹109.91
Total Equity & Liabilities₹213.88₹174.71₹157.03₹134.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹206.19₹156.45₹164.07₹144.00
Other Income₹5.41₹3.91₹1.75₹1.94
Total Revenue₹211.60₹160.36₹165.82₹145.94
Total Expenses₹173.43₹136.00₹134.29₹117.83
Profit Before Tax₹38.17₹24.37₹31.53₹28.12
Tax₹10.73₹6.10₹7.87₹7.09
Profit After Tax₹27.45₹18.27₹23.66₹21.02
EPS - Basic₹6.64₹22.11₹28.64₹25.44
EPS - Diluted₹6.64₹22.11₹28.64₹25.44

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹38.17₹24.37₹31.53₹28.12
Income before WC changes₹45.37₹29.66₹36.29₹31.64
Change in Assets-₹11.56-₹6.34-₹5.77-₹6.27
Change in Liabilities₹5.17₹2.80-₹1.51₹3.31
Change in WC-₹6.40-₹3.55-₹7.28-₹2.96
Cash flow from Operations₹30.42₹20.12₹21.15₹21.18
Cash flow from Investing-₹32.55-₹9.85-₹20.30-₹20.73
Cash flow from Financing-₹1.53-₹7.98-₹2.87-₹2.40
Total Cash Flow-₹3.65₹2.29-₹2.02-₹1.95
Cash (Start of the year)₹5.13₹2.84₹4.86₹6.81
Cash (End of the year)₹1.48₹5.13₹2.84₹4.86

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹117.94₹86.93₹79.40₹62.39
Current Assets₹85.24₹79.51₹72.17₹68.31
Total Assets₹203.18₹166.44₹151.57₹130.70
Current Liabilities₹25.96₹17.74₹19.13₹20.35
Net Current Asset₹59.28₹61.77₹53.05₹47.96
Non-Current Liabilities₹6.37₹3.57₹4.00₹4.25
Equity Capital₹170.84₹145.13₹128.44₹106.09
Total Equity & Liabilities₹203.18₹166.44₹151.57₹130.70
* All values are in INR Crore
TITAN BIOTECH LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
0041243
00413.553
0000
0000
0000
Total bid quantity0
Total ask quantity46
TITAN BIOTECH LTD. technical summary
Bearish indicators4
Neutral indicators2
Bullish indicators2
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
75.32
Bullish

ATR (14)
22.11
Neutral

STOCH(9,6)
91.59
Bearish

STOCH RSI (14)
100
Bearish

ADX(9)
34.4
Bearish

UO(9)
59.16
Neutral

ROC(12)
27.01
Bullish

WillR(14)
-6.47
Bearish
Period
Simple value
Exponential vaue

5D
388.86
393.05

10D
370.71
376.71

20D
351.74
359.43

50D
334.09
341.54

100D
328.48
334.49
Volume trend — traded volume by day
18 Nov0L
17 Nov1L
16 Nov1L
13 Nov0L
12 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

TITAN BIOTECH LTD.
Pharmaceuticals
Add Stock
Add Another

TITAN BIOTECH LTD. Returns Calculator

Ex-date: 23 Oct 2026

Ex-date: 22 Sep 2026

Ex-date: 20 Feb 2026

TITAN BIOTECH LTD. Share Price FAQs












Please be aware that TITAN BIOTECH LTD. stock prices are subject to continuous fluctuations due to various factors.